Mr Marco Aurélio Torronteguy > TozziniFreire Advogados > Sao Paulo, Brazil > Lawyer Profile

TozziniFreire Advogados
CEP 04038-904

Work Department

Life Sciences & Healthcare, Agribusiness




Partner in TozziniFreire´s Life Sciences and Healthcare practice group, Marco Aurélio has broad experience in regulatory matters and administrative health regulatory proceedings. He assists clients in several sectors of the industry, besides assisting health service providers. He also acts in regulatory consulting and administrative proceedings, especially before ANVISA (Brazilian Health Regulatory Agency) and MAPA (Brazilian Ministry of Agriculture, Livestock and Food Supply), as well as in matters involving the licensing and registration of products subject to health surveillance, new technologies, the launch of new products in the Brazilian market and drug recall.




  • Privacy and Data Protection course from Data Privacy Brasil, 2020.
  • Former Vice-Chair of the Health Law Committee of OAB/SP (Brazilian Bar Association, São Paulo section).
  • Former Counselor at the CNS (National Health Council), 2nd Alternate, representing MOPEM (Multiple Sclerosis Movement).


  • Doctor of Laws from USP (Universidade de São Paulo), 2010.
  • Specialized degree in Health Law from USP, 2010.
  • Master’s degree from UFSM (Universidade Federal de Santa Maria), 2006.
  • Graduate of the Law School of UFSM, 2003.

Lawyer Rankings

Brazil > Life sciences

Praised for its ‘excellent service’ and ability to offer clients ‘comprehensive advice covering all relevant legal areas and commercial aspects’, TozziniFreire Advogados’ life sciences offering is multidisciplinary in nature, with strong regulatory expertise. Recent highlights include advising on vaccine manufacture, ventilator regulation and medical device refurbishment during the Covid-19 pandemic. The ‘client focused’ Marco Aurélio Torronteguy heads up the practice and is a go-to partner in the firm for all manner of regulatory matters. Senior associate Victor Hugo Callejon Avallone is also of note within the team, particularly for advice on clinical trials, administrative proceedings and health-sector M&A. Pro bono work continues to be a standout area for the firm, particularly in providing legal assistance to NGOs and similar entities.